9th Congress of the International Society
for the Study of Iron in Biology and Medicine

27 August - 31 August 2023

Darwin Convention Centre, Darwin, Northern Territory, Australia

Register Now

For more information on ticket prices, availability and how to purchase, click below.

Call for Abstracts

For more information on how to submit an abstract and present at the conference, click below.

Present

Sponsor

For information on available sponsorship and exhibition opportunities, click below.

Sponsor

keynote Speakers

Dr Marcus Conrad

German Research Center for Environmental Health, Germany
Institute of Metabolism and Cell Death

Marcus Conrad studied biology at the University of Konstanz, before moving to Munich to perform his dissertation at Helmholtz Zentrum München. In 2001, he received his PhD from Ludwig-Maximilians-University Munich with distinction. After a short postdoctoral period, he became independent group leader at Helmholtz Zentrum München. During this period, he additionally conducted research at Karolinska Institute, Sweden, and Yamagata University, Japan. From 2009 – 2010 he was employed as Laboratory Head at Bayer-Schering AG, Berlin, whereupon he relocated to Munich to join the newly founded German Center for Neurodegenerative Diseases. As research group leader he returned to Helmholtz Zentrum München from 2012 – 2019. In 2020, he was appointed Director of the Institute of Metabolism and Cell Death, which focuses on studying the molecular mechanisms of oxidative cell death as the basis for the development of novel pharmacotherapies for treating (neuro)degenerative diseases and cancer. Marcus Conrad has published more than 150 publications and book chapters which have been cited already more than 32,000 times. He holds several patents, is co-founder and shareholder of ROSCUE Therapeutics GmbH and organized several internationally renowned conferences. He is member of the Advisory Board of Molecular Cell and was recently appointed as a new member of the Hinterzarten Circle of the Deutsche Forschungsgemeinschaft (DFG) on cancer research.

Dr paul adams

Department of Medicine, Division of Gastroenterology, Western University, London, Ontario

Dr. Adams (MD,Queen’s University,Kingston 1980) completed an internship and residency training in Toronto. He did further training at Mount Sinai Hospital, New York and completed a Fellowship in Gastroenterology at the University of California at San Francisco (UCSF). He also worked at the Liver Research Unit of the Royal Brisbane Hospital,,Australia..He has previously been the Editor-in-Chief of the Canadian Journal of Gastroenterology (2005-2010) and the Chief of the Division of Gastroenterology at Western (2007-2017). He has been funded continuously by the National Institute of Health (Bethesda, MD) for the past 20 years. He currently has 348 publications including papers in the New England Journal of Medicine, Nature Genetics, JAMA, Gastroenterology, Hepatology, Annals of Internal Medicine, and Lancet. He has received the Commemorative Medal for the Golden Jubilee of Her Majesty Queen Elizabeth II. In 2010 he received the Gold Medal from the Canadian Association for the Study of the Liver and the Canadian Liver Foundation. In 2019, he received the Marcel Simon Award presented in Heidelberg,Germany (May 2019) for lifetime research achievement in hemochromatos. He is an invited author of a recent Seminar on Haemochromatosis for The Lancet 2023.

Dr Elizabeta Nemeth

Professor of Medicine at the David Geffen School of Medicine at UCLA, and Director of the UCLA Center for Iron Disorders

Dr. Nemeth received her BS in Molecular Biology at the University of Belgrade, Yugoslavia, and a PhD in Cell, Molecular and Neurosciences at the University of Hawaii. She joined UCLA in 2002, and since then has been studying the molecular basis of iron homeostasis and pathogenesis of iron disorders, with specific focus on the function of the hepatic peptide hormone hepcidin and its receptor, iron transporter ferroportin. Her work helped define the regulation of hepcidin production by iron, inflammation and erythropoiesis, the role of hepcidin in different iron disorders including hereditary hemochromatosis, β-thalassemia, and anemia of inflammation, as well as its roles in innate immunity and iron regulation in pregnancy. She contributed to the elucidation of the mechanism of action of hepcidin as the ligand of ferroportin, and to the discovery of a novel hepcidin-regulating hormone erythroferrone. Dr. Nemeth has co-founded three biotechnology companies focused on hepcidin-targeted diagnostics and therapeutics.

Dr. Nemeth currently serves on the NIH Innovative Science Accelerator (ISAC) Program panel, is an Associate Editor of the American Journal of Hematology, and President-Elect of the International Bioiron Society. She is involved in career development of junior faculty, postdoctoral fellows and graduate students at UCLA as a co-director of the UCLA K program for young faculty, director of NIDDK-sponsored training grant for pre- and postdoc trainees, and executive committee member of a UCLA graduate program in molecular physiology. Dr. Nemeth received Grace Goldsmith Award from the American College of Nutrition in 2007 for significant contributions to the field of nutrition, BioIron Presidential Award in 2019 for seminal work on the mode of action of hepcidin and the molecular basis of systemic iron homeostasis, and the William Dameshek Prize from the American Society of Hematology in 2021 for outstanding contribution to the field of hematology.

Welcome

Dear friends and colleagues,

We would like to welcome you to Australia for the Ninth Congress of the International Society for the Study of Iron in Biology and Medicine (BioIron 2023). The conference will be held at the Darwin Convention Centre in the tropical north of Australia.

The bioiron area continues to expand and diversify, with important advances and discoveries both in fundamental aspects of iron homeostasis and iron-related disorders. BioIron 2023 will highlight the best of these advances, and will provide a stimulating environment for scientific discussion and exchange. Whether you are an experienced iron worker or just starting out in this fascinating field, there will be something to hold your attention.

The scientific program was planned by the Local Organizing Committee (LOC) in collaboration with the BioIron Society Board. The educational activities that have been held at the last few BioIron meetings, the Introductory Course and the Meet-the-Expert breakfasts, have proved to be a great success and will be held again at BioIron 2023. While the Meet-the-Expert sessions are specifically aimed at students and early career investigators, all delegates are welcome to attend the Introductory Course.

The BioIron Society and conference organisers support and encourage the attendance of postgraduate students and early career researchers at BioIron 2023 and will provide some financial support for selected applicants. If you wish to apply for a bursary to support your attendance at the conference, please submit an application via the Bursaries tab at the top of this page.

Darwin is a small city by world standards, but it boasts excellent infrastructure and is a culturally vibrant destination, with a mix of Indigenous, European and Asian cultures. It is also the hub of an area of outstanding natural beauty, with the jewel in the crown being Kakadu National Park, a UNESCO World Heritage Site. We hope you will take advantage of your time in Australia to interact with the local people and enjoy some of the fine attractions and wonderful cuisine that the Northern Territory has to offer.

We wish to warmly thank all our sponsors for their generous contributions to this event, and especially their support of the educational activities and bursaries. Without their support it would be much more difficult to organize an event such as this.

We look forward to seeing you in Darwin.

Local Organising Committee: Grant Ramm, Nathan Subramaniam, Greg Anderson

BioIron Society President: Martina Muckenthaler

BioIron Society President-Elect: Ella Nemeth